Similar articles for PMID: 7803263

Year	Number of Results
1985	1
1988	1
1989	1
1990	1
1991	1
1992	2
1993	4
1994	4
1995	2
1996	5
1997	2
1998	1
1999	5
2000	3
2001	4
2002	5
2003	5
2004	3
2005	2
2006	3
2007	3
2008	4
2009	1
2010	3
2011	1
2012	3
2013	3
2014	2
2015	5
2016	2
2017	1
2018	2
2024	0

1

Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen.

Kantarjian HM, O'Brien S, Smith T, Estey EH, Beran M, Preti A, Pierce S, Keating MJ. Kantarjian HM, et al. Br J Haematol. 1994 Sep;88(1):94-100. doi: 10.1111/j.1365-2141.1994.tb04982.x. Br J Haematol. 1994. PMID: 7803263

2

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.

Kantarjian HM, Walters RS, Keating MJ, Smith TL, O'Brien S, Estey EH, Huh YO, Spinolo J, Dicke K, Barlogie B, et al. Kantarjian HM, et al. J Clin Oncol. 1990 Jun;8(6):994-1004. doi: 10.1200/JCO.1990.8.6.994. J Clin Oncol. 1990. PMID: 2189958 Clinical Trial.

3

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.

Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ. Kantarjian H, et al. Cancer. 2004 Dec 15;101(12):2788-801. doi: 10.1002/cncr.20668. Cancer. 2004. PMID: 15481055 Free article. Clinical Trial.

4

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.

Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ. Kantarjian HM, et al. J Clin Oncol. 2000 Feb;18(3):547-61. doi: 10.1200/JCO.2000.18.3.547. J Clin Oncol. 2000. PMID: 10653870 Clinical Trial.

5

Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia.

O'Brien S, Thomas DA, Ravandi F, Faderl S, Pierce S, Kantarjian H. O'Brien S, et al. Cancer. 2008 Oct 15;113(8):2097-101. doi: 10.1002/cncr.23819. Cancer. 2008. PMID: 18720356 Free PMC article.

6

Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.

Cortes J, Fayad L, O'Brien S, Keating M, Kantarjian H. Cortes J, et al. Clin Cancer Res. 1999 Sep;5(9):2491-7. Clin Cancer Res. 1999. PMID: 10499624 Clinical Trial.

7

Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis.

Preti HA, Huh YO, O'Brien SM, Andreeff M, Pierce ST, Keating M, Kantarjian HM. Preti HA, et al. Cancer. 1995 Nov 1;76(9):1564-70. doi: 10.1002/1097-0142(19951101)76:9<1564::aid-cncr2820760911>3.0.co;2-1. Cancer. 1995. PMID: 8635059

8

Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.

Faderl S, Kantarjian HM, Thomas DA, Cortes J, Giles F, Pierce S, Albitar M, Estrov Z. Faderl S, et al. Leuk Lymphoma. 2000 Jan;36(3-4):263-73. doi: 10.3109/10428190009148847. Leuk Lymphoma. 2000. PMID: 10674898

9

Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia.

Kantarjian HM, Walters RS, Keating MJ, Barlogie B, McCredie KB, Freireich EJ. Kantarjian HM, et al. Cancer. 1989 Jul 1;64(1):16-22. doi: 10.1002/1097-0142(19890701)64:1<16::aid-cncr2820640104>3.0.co;2-o. Cancer. 1989. PMID: 2659160

10

Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group.

Ohno R, Kobayashi T, Tanimoto M, Hiraoka A, Imai K, Asou N, Tomonaga M, Tsubaki K, Takahashi I, Kodera Y, et al. Ohno R, et al. Cancer. 1993 Jun 15;71(12):3888-95. doi: 10.1002/1097-0142(19930615)71:12<3888::aid-cncr2820711216>3.0.co;2-g. Cancer. 1993. PMID: 8508355 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year